General surgery residency program, University of Milan, Milan, Italy.
Colon and Rectal Surgery Division, Humanitas Clinical and Research Center - IRCCS -, via Manzoni 56, 20089 Rozzano (Mi), Italy.
Curr Drug Targets. 2021;22(1):112-116. doi: 10.2174/1389450121999200820125918.
Surgery is considered a cornerstone of inflammatory bowel disease (IBD) treatment. In the last years, robotic surgery has seen an increase in adoption rates for both benign and malignant diseases.
This work aims to review the current applications of robotic surgery in IBD.
Minimally-invasive techniques have been applied to the treatment of IBD for more than 20 years. Investments in surgical digital and robotic platforms are increasingly arising, with an estimate of getting doubled within the next 5 years. Robotic surgery represents the newest technology available to reduce the impact of surgery on patients affected by IBD, and may theoretically be even more effective than other minimally-invasive techniques given the lower rate of conversion to open surgery as compared to laparoscopy according to many large retrospective series. Data on robotic surgery applied to IBD are still scarce and initial experiences in high-volume centers from retrospective series suggested that robotic surgery may achieve similar results when compared to laparoscopy. A new wave of robotics incorporating artificial intelligence is awaited to empower the capability of IBD surgeon in terms of intraoperative decision-making beyond technical skill enhancement.
手术被认为是炎症性肠病（IBD）治疗的基石。近年来，机器人手术在治疗良性和恶性疾病方面的采用率有所提高。
本研究旨在综述机器人手术在 IBD 中的应用。
微创技术在 IBD 治疗中已经应用了 20 多年。对手术数字化和机器人平台的投资正在不断增加，预计在未来 5 年内将增加一倍。机器人手术是一种新技术，可减轻 IBD 患者手术带来的影响，与腹腔镜手术相比，根据许多大型回顾性系列研究，机器人手术的中转开腹率较低，理论上可能比其他微创技术更有效。关于机器人手术在 IBD 中的应用数据仍然有限，来自高容量中心的回顾性系列初步经验表明，与腹腔镜手术相比，机器人手术可能取得相似的结果。预计将迎来一波新的人工智能机器人技术浪潮，以增强 IBD 外科医生的术中决策能力，而不仅仅是提高技术技能。
